ImmuCell Corporation.
ICCC.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
ImmuCell Corporation is a biotechnology company focused on developing, manufacturing, and marketing products that improve the health and productivity of dairy and beef cattle. Their primary product is First Defense®, an orally administered colostrum-derived antibody product that provides immediate i...Show More
Better Health for All
0
No evidence available to assess ImmuCell Corporation on Better Health for All.
Fair Money & Economic Opportunity
0
ICCC.US is a biotechnology company focused on developing, manufacturing, and marketing products for dairy and beef cattle, such as First Defense®.
1
The provided articles detail its animal health products, market performance, and corporate financial information, including debt refinancing.
2
There is no evidence that ICCC.US operates as a financial institution or offers lending, deposit, or other financial services to consumers. Consequently, all KPIs under 'Fair Money & Economic Opportunity' are not applicable to the company's core business model.
Fair Pay & Worker Respect
0
No specific regulatory actions, violations, fines, or compliance issues are mentioned in the employee reviews from Indeed.com.
1
Glassdoor reviews also do not contain quantitative data regarding labor violations.
2
Fair Trade & Ethical Sourcing
0
No specific, quantitative data points related to fair trade and ethical sourcing, such as fair-trade certification share, audit frequency, forced/child labor incidents, traceability coverage, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend, were found in the provided article.
1
Honest & Fair Business
-50
The company has a Whistle-blower Policy that states it will not permit retaliation against good faith reports of violations.
1
Additionally, an executive's ability to report possible violations of federal law or regulation to governmental agencies is protected without prior authorization or notification to the company.
2
However, details on hotline, training, or independent investigation processes are not provided. The company restated its Quarterly Reports on Form 10-Q for the three-month periods ended June 30, 2022, and March 31, 2022, during 2022.
3
This represents one restatement over the past five years. Two of the company's directors are employees (Mr. Brigham and Ms. Brockmann), while the remaining directors qualify as independent under NASDAQ Stock Market rules.
4
The company adopted a Code of Business Conduct and Ethics in December 2003, with minor revisions in March 2014, which includes a commitment not to condone activities that violate the law or involve unethical business dealings, such as bribery.
5
It also states compliance with the Sarbanes-Oxley Act of 2002 and prohibits loans to directors or officers.
6
Kind to Animals
0
No specific, concrete data points were found in the provided articles regarding ImmuCell Corporation's cruelty-free certifications, use of alternative testing methods, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audit percentages for welfare compliance, cage-free sourcing, animal testing policies or volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement related to animal welfare.
1
The articles primarily focus on financial performance, product development, and regulatory approvals (USDA, FDA, OMRI), which are not directly relevant to the defined animal welfare KPIs.
No War, No Weapons
0
No data relevant to the 'No War, No Weapons' ethical value for ImmuCell Corporation (ICCC.US) was found in the provided articles. The articles explicitly state that sustainability data is unavailable and no information pertaining to the requested metrics could be extracted.
1
Planet-Friendly Business
-40
The company received one deficiency on the FDA’s Form 483 following a pre-approval inspection of its DS facility in the first quarter of 2024.
1
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles to assess ICCC.US against any of the KPIs for 'Respect for Cultures & Communities'. The articles primarily consist of job postings, employment applications, and employee reviews, none of which contain information regarding community partnerships, cultural impact assessments, local employment ratios, grievance mechanisms, or any other relevant metrics for this value.
1
Safe & Smart Tech
0
No evidence available to assess ImmuCell Corporation on Safe & Smart Tech.
Zero Waste & Sustainable Products
-70
The company does not mention specific waste reduction targets or metrics.
1
There are no specific waste reduction requirements for suppliers.
2
Additionally, no customer waste education programs are mentioned.
3